Chemical segment uptick to improve H2 growth for chemicals maker SRF

Based on global chemical firms' outlook, analysts expect SRF to continue to benefit from strong volume-led recovery in agrochem globally, resilient R32 demand & modest demand growth outlook

SRF, Stock Market, BSE, NSE, SRF Limited, Chemicals, Chemical Industry, ICICI Securities
Ram Prasad Sahu
4 min read Last Updated : Dec 15 2025 | 10:37 PM IST
The stock of the country’s largest listed specialty chemicals maker by market capitalisation, SRF, has gained about 6 per cent over the past week. While its performance in the second quarter (July-September) of 2025-26 (Q2FY26) was a mixed bag, brokerages expect upsides due to strong prospects for its core chemicals business.
 
They expect the second half of the current financial year (H2FY26) to be better than the first on better volumes, prices, and output of new products. At the current price, the stock, which has gained about 30 per cent over the past year, is trading at 36 times its FY26 earnings per share (EPS).
 
ICICI Securities is positive about the prospects of the chemicals business going ahead. The performance, according to analysts led by Sanjesh Jain of ICICI Securities, could improve across refrigerant gases, specialty chemicals and fluoropolymers.
 
Higher volumes and sustained prices present a 15-20 per cent upside risk in the refrigerant gas business. The brokerage remains optimistic about hydrofluorochemical (HFC) prices – complemented by positive industry dynamics. Specialty chemicals should benefit from a favourable price base and greater volumes, which, coupled with new product commissioning, may spur growth in H2FY26. H1FY26 saw a low single-digit revenue growth. 
 
Going into calendar year 2026 (CY26), with channel inventory and oversupply-related concerns behind, JM Financial Research expects a pick-up in demand for non-generic agrochemicals and related specialty chemicals, driven by a likely improvement in farmer profitability, especially in North America.
 
Non-generic agrochemicals may be preferred globally in CY27 on the back of a likely contraction in crop supplies in CY26, which bodes well for improvement in crop prices. Within its coverage universe, analysts led by Krishan Parwani of the brokerage believe that SRF should benefit from this phenomenon given a large part of its growth in FY27 is set to come from the ramp-up of new active ingredients.
 
In Q2FY26, it was the chemicals segment which helped the company offset the weakness in the packaging products. While the chemical business reported a growth of 23 per cent year-on-year (Y-o-Y), led by fluorochemical volumes and realisations, overall revenue growth at 6 per cent was lower than estimates.
 
On a sequential basis, however, both the chemicals and the packaging segments saw a decline. The chemical segment’s quarter-on-quarter (Q-o-Q) was hampered by headwinds from Chinese competition and US tariff uncertainty, which led customers to defer their procurements. The chemicals business accounted for 46 per cent of revenue and 74 per cent of the profits at the operating level. SRF reiterated its 20 per cent revenue growth guidance for the chemicals segment in FY26, led by strong R-32 demand, fluoropolymers growth, and a continued recovery in global agrochem demand. R-32 is a chemical compound known as difluoromethane, which is widely used as an environmentally friendlier refrigerant in air conditioning and heat pump systems.
 
Based on global chemical firms’ outlook, analysts led by Gagan Dixit of Elara Securities expect SRF to continue to benefit from strong volume-led recovery in agrochem globally, resilient R-32 demand, and modest demand growth outlook for packaging. Ramp-up at the PTFE fluoropolymer plant (polytetrafluoroethylene) and continued agrochem demand recovery in the specialty chemical segment would be the key earning growth drivers, they add.
 
A few hiccups in the near term due to persistent global headwinds in agrochemicals may defer demand, believes Nuvama Research, but would not derail the China +1 theme. Tailwinds in HFC gases will keep margins buoyant, resonating with “our positive stance”, says the brokerage. While the segment margin of the chemical business expanded to 28.9 per cent in Q2FY26 as compared to 18.1 per cent in Q2FY25 and 27.3 per cent in Q1FY26, the packaging business expanded by 262 basis points (bps) Y-o-Y to 8.4 per cent.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Stock MarketSRFSRF stockICICI SecuritiesStock Analysis

Next Story